Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.37 -0.55 (-3.69%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Cash & Current Investments (2020 - 2026)

Updated

Cullinan Therapeutics' Cash & Current Investments came in at $334.5 million for Q2 2026, up 26.0% from $265.5 million a year earlier but down 4.9% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Cullinan Therapeutics' Cash & Current Investments was $377.9 million, down 5.3% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 12.4% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $399 million in FY2024 (-14.6%), $467.07 million in FY2023 (unchanged), $467.29 million in FY2022 (+60.9%) and $290.47 million in FY2021 (+38.2%).
  • The five-year range for quarterly Cash & Current Investments is $265.5 million (Q2 2025) to $662.5 million (Q2 2024).
  • Year-over-year, Cash & Current Investments increased in three of the last eight quarters, with an average decline of 10.8%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2022 (growth of 81.5%), and the weakest in Q2 2025 (a decline of 59.9%).
  • Business Quant data shows CGEM's Cash & Current Investments at $351.9 million (Q1 2026), $377.9 million (Q4 2025) and $332.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Cullinan Therapeutics 894.26 Mn 559.76 Mn - 334.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 334.50 Mn
Mar 31, 2026 351.90 Mn
Dec 31, 2025 377.90 Mn
Sep 30, 2025 332.60 Mn
Jun 30, 2025 265.50 Mn
Mar 31, 2025 303.80 Mn
Dec 31, 2024 399.00 Mn
Sep 30, 2024 578.10 Mn
Jun 30, 2024 662.50 Mn
Mar 31, 2024 433.01 Mn
Dec 31, 2023 467.07 Mn
Sep 30, 2023 466.43 Mn
Jun 30, 2023 491.80 Mn
Mar 31, 2023 390.70 Mn
Dec 31, 2022 467.29 Mn
Sep 30, 2022 575.95 Mn
Jun 30, 2022 611.00 Mn
Mar 31, 2022 314.85 Mn
Dec 31, 2021 290.47 Mn
Sep 30, 2021 321.04 Mn
API Access

Cullinan Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CGEM&period=max&api_key=YOUR_API_KEY